Heron Therapeutics, Inc. is a high-risk pharmaceutical company based in the United States. Specializing in commercial-stage biotechnology, Heron Therapeutics is dedicated to enhancing patient lives with innovative treatments that target unmet needs. Their product lineup includes APONVIE, SUSTOL, ZYNRELEF, and CINVANTI. The company has an ESG score of 30.8.